Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Colloquium supported by Novartis - Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation

Clinical drug development of radiotheranostics: Trial design, administered vs absorbed dose and the role of internal dosimetry

Date

04 Mar 2025

Session

ESMO Colloquium supported by Novartis - Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation

Topics

Nuclear Medicine and Clinical Molecular Imaging;  Targeted Therapy

Tumour Site

Breast Cancer;  Neuroendocrine Neoplasms;  Prostate Cancer

Presenters

Alessandra Gennari

Authors

A. Gennari

Author affiliations

  • Dipartimento Di Medicina Traslazionale - Dimet, Università Degli Studi Del Piemonte Orientale Amedeo Avogadro - Scuola di Medicina, 28100 - Novara/IT

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.